Predicting a window of therapeutic opportunity in multiple sclerosis

ISSN： 1460-2156

Source： Brain, Vol.133, Iss.7, 2010-07, pp. : 1863-1865

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An examination of four models predicting fatigue in multiple sclerosis

By Strober Lauren B. Arnett Peter A.

Archives of Clinical Neuropsychology, Vol. 20, Iss. 5, 2005-07 ,pp. : 631-646

Oxford University Press

Access to resources Recommend Favorite

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

By Opdenakker G. Nelissen I. Van Damme J.

Lancet Neurology, Vol. 2, Iss. 12, 2003-12 ,pp. : 747-756

Elsevier

Access to resources Recommend Favorite

Dendritic cells in the CNS: immune regulators and therapeutic targets for multiple sclerosis treatment

By Zozulya Alla L Reinke Emily K Ling Changying Sandor Matyas Fabry Zsuzsanna

Future Neurology, Vol. 2, Iss. 1, 2007-01 ,pp. : 97-106

Future Medicine

Access to resources Recommend Favorite

Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair

By Markovic-Plese Silva Singh Avtar K Singh Inderjit

Future Neurology, Vol. 3, Iss. 2, 2008-03 ,pp. : 153-167

Future Medicine

Access to resources Recommend Favorite

Functional system scores provide a window into disease activity occurring during a multiple sclerosis treatment trial

By Scott T F You X Foulds P

Neurological Research, Vol. 33, Iss. 5, 2011-06 ,pp. : 549-552

Maney Publishing

Access to resources Recommend Favorite